Cargando…
Deep Phenotyping of Parkinson’s Disease
Phenotype is the set of observable traits of an organism or condition. While advances in genetics, imaging, and molecular biology have improved our understanding of the underlying biology of Parkinson’s disease (PD), clinical phenotyping of PD still relies primarily on history and physical examinati...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458535/ https://www.ncbi.nlm.nih.gov/pubmed/32444562 http://dx.doi.org/10.3233/JPD-202006 |
_version_ | 1783576218749108224 |
---|---|
author | Dorsey, E. Ray Omberg, Larsson Waddell, Emma Adams, Jamie L. Adams, Roy Ali, Mohammad Rafayet Amodeo, Katherine Arky, Abigail Augustine, Erika F. Dinesh, Karthik Hoque, Mohammed Ehsan Glidden, Alistair M. Jensen-Roberts, Stella Kabelac, Zachary Katabi, Dina Kieburtz, Karl Kinel, Daniel R. Little, Max A. Lizarraga, Karlo J. Myers, Taylor Riggare, Sara Rosero, Spencer Z. Saria, Suchi Schifitto, Giovanni Schneider, Ruth B. Sharma, Gaurav Shoulson, Ira Stevenson, E. Anna Tarolli, Christopher G. Luo, Jiebo McDermott, Michael P. |
author_facet | Dorsey, E. Ray Omberg, Larsson Waddell, Emma Adams, Jamie L. Adams, Roy Ali, Mohammad Rafayet Amodeo, Katherine Arky, Abigail Augustine, Erika F. Dinesh, Karthik Hoque, Mohammed Ehsan Glidden, Alistair M. Jensen-Roberts, Stella Kabelac, Zachary Katabi, Dina Kieburtz, Karl Kinel, Daniel R. Little, Max A. Lizarraga, Karlo J. Myers, Taylor Riggare, Sara Rosero, Spencer Z. Saria, Suchi Schifitto, Giovanni Schneider, Ruth B. Sharma, Gaurav Shoulson, Ira Stevenson, E. Anna Tarolli, Christopher G. Luo, Jiebo McDermott, Michael P. |
author_sort | Dorsey, E. Ray |
collection | PubMed |
description | Phenotype is the set of observable traits of an organism or condition. While advances in genetics, imaging, and molecular biology have improved our understanding of the underlying biology of Parkinson’s disease (PD), clinical phenotyping of PD still relies primarily on history and physical examination. These subjective, episodic, categorical assessments are valuable for diagnosis and care but have left gaps in our understanding of the PD phenotype. Sensors can provide objective, continuous, real-world data about the PD clinical phenotype, increase our knowledge of its pathology, enhance evaluation of therapies, and ultimately, improve patient care. In this paper, we explore the concept of deep phenotyping—the comprehensive assessment of a condition using multiple clinical, biological, genetic, imaging, and sensor-based tools—for PD. We discuss the rationale for, outline current approaches to, identify benefits and limitations of, and consider future directions for deep clinical phenotyping. |
format | Online Article Text |
id | pubmed-7458535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-74585352020-09-11 Deep Phenotyping of Parkinson’s Disease Dorsey, E. Ray Omberg, Larsson Waddell, Emma Adams, Jamie L. Adams, Roy Ali, Mohammad Rafayet Amodeo, Katherine Arky, Abigail Augustine, Erika F. Dinesh, Karthik Hoque, Mohammed Ehsan Glidden, Alistair M. Jensen-Roberts, Stella Kabelac, Zachary Katabi, Dina Kieburtz, Karl Kinel, Daniel R. Little, Max A. Lizarraga, Karlo J. Myers, Taylor Riggare, Sara Rosero, Spencer Z. Saria, Suchi Schifitto, Giovanni Schneider, Ruth B. Sharma, Gaurav Shoulson, Ira Stevenson, E. Anna Tarolli, Christopher G. Luo, Jiebo McDermott, Michael P. J Parkinsons Dis Review Phenotype is the set of observable traits of an organism or condition. While advances in genetics, imaging, and molecular biology have improved our understanding of the underlying biology of Parkinson’s disease (PD), clinical phenotyping of PD still relies primarily on history and physical examination. These subjective, episodic, categorical assessments are valuable for diagnosis and care but have left gaps in our understanding of the PD phenotype. Sensors can provide objective, continuous, real-world data about the PD clinical phenotype, increase our knowledge of its pathology, enhance evaluation of therapies, and ultimately, improve patient care. In this paper, we explore the concept of deep phenotyping—the comprehensive assessment of a condition using multiple clinical, biological, genetic, imaging, and sensor-based tools—for PD. We discuss the rationale for, outline current approaches to, identify benefits and limitations of, and consider future directions for deep clinical phenotyping. IOS Press 2020-07-28 /pmc/articles/PMC7458535/ /pubmed/32444562 http://dx.doi.org/10.3233/JPD-202006 Text en © 2020 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Dorsey, E. Ray Omberg, Larsson Waddell, Emma Adams, Jamie L. Adams, Roy Ali, Mohammad Rafayet Amodeo, Katherine Arky, Abigail Augustine, Erika F. Dinesh, Karthik Hoque, Mohammed Ehsan Glidden, Alistair M. Jensen-Roberts, Stella Kabelac, Zachary Katabi, Dina Kieburtz, Karl Kinel, Daniel R. Little, Max A. Lizarraga, Karlo J. Myers, Taylor Riggare, Sara Rosero, Spencer Z. Saria, Suchi Schifitto, Giovanni Schneider, Ruth B. Sharma, Gaurav Shoulson, Ira Stevenson, E. Anna Tarolli, Christopher G. Luo, Jiebo McDermott, Michael P. Deep Phenotyping of Parkinson’s Disease |
title | Deep Phenotyping of Parkinson’s Disease |
title_full | Deep Phenotyping of Parkinson’s Disease |
title_fullStr | Deep Phenotyping of Parkinson’s Disease |
title_full_unstemmed | Deep Phenotyping of Parkinson’s Disease |
title_short | Deep Phenotyping of Parkinson’s Disease |
title_sort | deep phenotyping of parkinson’s disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458535/ https://www.ncbi.nlm.nih.gov/pubmed/32444562 http://dx.doi.org/10.3233/JPD-202006 |
work_keys_str_mv | AT dorseyeray deepphenotypingofparkinsonsdisease AT omberglarsson deepphenotypingofparkinsonsdisease AT waddellemma deepphenotypingofparkinsonsdisease AT adamsjamiel deepphenotypingofparkinsonsdisease AT adamsroy deepphenotypingofparkinsonsdisease AT alimohammadrafayet deepphenotypingofparkinsonsdisease AT amodeokatherine deepphenotypingofparkinsonsdisease AT arkyabigail deepphenotypingofparkinsonsdisease AT augustineerikaf deepphenotypingofparkinsonsdisease AT dineshkarthik deepphenotypingofparkinsonsdisease AT hoquemohammedehsan deepphenotypingofparkinsonsdisease AT gliddenalistairm deepphenotypingofparkinsonsdisease AT jensenrobertsstella deepphenotypingofparkinsonsdisease AT kabelaczachary deepphenotypingofparkinsonsdisease AT katabidina deepphenotypingofparkinsonsdisease AT kieburtzkarl deepphenotypingofparkinsonsdisease AT kineldanielr deepphenotypingofparkinsonsdisease AT littlemaxa deepphenotypingofparkinsonsdisease AT lizarragakarloj deepphenotypingofparkinsonsdisease AT myerstaylor deepphenotypingofparkinsonsdisease AT riggaresara deepphenotypingofparkinsonsdisease AT roserospencerz deepphenotypingofparkinsonsdisease AT sariasuchi deepphenotypingofparkinsonsdisease AT schifittogiovanni deepphenotypingofparkinsonsdisease AT schneiderruthb deepphenotypingofparkinsonsdisease AT sharmagaurav deepphenotypingofparkinsonsdisease AT shoulsonira deepphenotypingofparkinsonsdisease AT stevensoneanna deepphenotypingofparkinsonsdisease AT tarollichristopherg deepphenotypingofparkinsonsdisease AT luojiebo deepphenotypingofparkinsonsdisease AT mcdermottmichaelp deepphenotypingofparkinsonsdisease |